What Happened?
Northbrook, IL-based Astellas Appointed Michael Rafa as Senior Vice President, Head of Intellectual Property Innovation and New Technologies
About the Company
Astellas Pharma US, Inc., a U.S. affiliate of Tokyo-based Astellas Pharma Inc., is a pharmaceutical company dedicated to changing tomorrow by improving the health of people around the world through innovative and reliable pharmaceutical products. In 2005, Astellas was formed by blending the talents, resources and passions of two highly successful firms - Yamanouchi and Fujisawa. Astellas aims to maintain and strengthen our position as the global leader in transplantation and urology areas, and going forward we are working to establish our position as a global category leader in oncology. At all levels throughout the company our people are committed to the opportunity to positively affect and improve patient lives while remaining socially responsible to our community and those with whom we work and collaborate.
About the Person
Michael Rafa is Senior Vice President, Head of Intellectual Property Innovation and New Technologies at Astellas. Previously, Michael held various senior IT leadership roles in the industry.
Info Source
News
Short Profile